We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+15.24%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$108M
Cap. Flow
+$12.9M
Cap. Flow %
1.28%
Top 10 Hldgs %
44.19%
Holding
122
New
21
Increased
49
Reduced
41
Closed
10

Sector Composition

Rank Sector Weight
1 Financials 0.66%
2 Consumer Discretionary 0.32%
3 Technology 0.27%
4 Energy 0.17%
5 Healthcare 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPE icon
51
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$6.07M 0.6%
+322,583
New +$5.82M
LRGF icon
52
iShares US Equity Factor ETF
LRGF
$3.52B
$4.81M 0.48%
148,963
+3,977
+3% +$118K
ISCF icon
53
iShares International Small Cap Equity Factor ETF
ISCF
$644M
$3.97M 0.39%
139,120
-76
-0.1% -$1.96K
AOK icon
54
iShares Core Conservative Allocation ETF
AOK
$806M
$3.53M 0.35%
95,262
-10,990
-10% -$389K
SWAN icon
55
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$160M
$3.15M 0.31%
100,019
+86,366
+633% +$2.58M
JPIN icon
56
JPMorgan Diversified Return International Equity ETF
JPIN
$360M
$3.12M 0.31%
60,696
-3,701
-6% -$175K
HYLB icon
57
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.51B
$3.01M 0.3%
78,264
+3,223
+4% +$119K
IJS icon
58
iShares S&P Small-Cap 600 Value ETF
IJS
$8.15B
$2.66M 0.26%
44,000
-678
-2% -$38K
AGGY icon
59
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$959M
$2.56M 0.25%
47,212
-626
-1% -$33.3K
VWO icon
60
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.03M 0.2%
47,179
+1,992
+4% +$73.7K
SMLF icon
61
iShares US Small Cap Equity Factor ETF
SMLF
$4.07B
$1.73M 0.17%
47,370
+1,286
+3% +$42.9K
VHT icon
62
Vanguard Health Care ETF
VHT
$18B
$1.56M 0.15%
7,624
-774
-9% -$145K
VEU icon
63
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.5M 0.15%
29,781
+2,596
+10% +$116K
AOR icon
64
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.63B
$927K 0.09%
19,431
-1,915
-9% -$85.1K
HBI
65
DELISTED
Hanesbrands
HBI
$843K 0.08%
60,281
-1,466
-2% -$14.7K
AAPL icon
66
Apple
AAPL
$4.9T
$822K 0.08%
+8,360
New +$648K
KHC icon
67
Kraft Heinz
KHC
$30.7B
$782K 0.08%
22,927
-340
-1% -$10.2K
VIG icon
68
Vanguard Dividend Appreciation ETF
VIG
$111B
$781K 0.08%
6,384
-67,359
-91% -$7.67M
IVZ icon
69
Invesco
IVZ
$13.1B
$768K 0.08%
74,648
+17,131
+30% +$154K
CNP icon
70
CenterPoint Energy
CNP
$28.2B
$741K 0.07%
38,638
+1,147
+3% +$19.8K
GILD icon
71
Gilead Sciences
GILD
$167B
$737K 0.07%
9,439
+1,473
+18% +$113K
PFG icon
72
Principal Financial Group
PFG
$24.6B
$700K 0.07%
15,952
-2,250
-12% -$82.1K
ABBV icon
73
AbbVie
ABBV
$450B
$680K 0.07%
6,834
-171
-2% -$15.1K
HPQ icon
74
HP
HPQ
$22.7B
$678K 0.07%
+38,402
New +$610K
DOW icon
75
Dow Inc
DOW
$21.6B
$661K 0.07%
15,629
-1,241
-7% -$45.4K

Similar funds

Trilogy Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Trilogy Capital held 122 positions worth $1.01B, up 12% from $904M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trilogy Capital's Q2 2020 filing shows 21 new, 49 increased, 41 reduced and 10 closed positions. Its largest new stake was Invesco QQQ Trust: 78,791 shares worth $21M. The largest sale was iShares Core Moderate Allocation ETF, an estimated $20.8M.

By sector, the portfolio is most concentrated in Financials at 0.66% of assets, up from 0.65% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Trilogy Capital's largest Q2 2020 buy was Invesco QQQ Trust: 78,791 shares worth $21M.
  • Trilogy Capital added most to iShares 7-10 Year Treasury Bond ETF in Q2 2020, an estimated $4M increase.
  • Trilogy Capital's biggest Q2 2020 reduction was iShares Core Moderate Allocation ETF, cutting an estimated $20.8M.
  • Trilogy Capital fully exited Vanguard Intermediate-Term Treasury ETF in Q2 2020, selling an estimated $6.18M.
  • Trilogy Capital's ten largest holdings make up 44% of its $1.01B portfolio in Q2 2020.
  • Trilogy Capital opened 21 new positions and closed 10 in Q2 2020.
  • Trilogy Capital's portfolio value rose 12% quarter-over-quarter to $1.01B.

Based on Trilogy Capital's 13F filing for Q2 2020, filed 22 Jul 2020.